Identification and optimization of peptide inhibitors to block VISTA/PSGL-1 interaction for cancer immunotherapy
Acta Pharmaceutica Sinica B · 2023-11 · 13 (11) · 4511-4522
DOI: 10.1016/j.apsb.2023.08.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2023-11. Verfasst von Xiaoshuang Niu und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Science, Technology and Innovation Commission of Shenzhen Municipality.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.
- School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
- International Joint Laboratory for Protein and Peptide Drugs of Henan Province, Zhengzhou University, Zhengzhou 450001, China.
Förderung
- National Natural Science Foundation of China
- Science, Technology and Innovation Commission of Shenzhen Municipality
Zitieren
APA
Niu, X., Wu, M., Li, G., Zhou, X., Cao, W., Zhai, W., Wu, A., Zhou, X., Jin, S., Chen, G., Li, Y., Du, J., Wu, Y., Qiu, L., Zhao, W., & Gao, Y. (2023). Identification and optimization of peptide inhibitors to block VISTA/PSGL-1 interaction for cancer immunotherapy. Acta Pharmaceutica Sinica B, 13(11), 4511-4522. https://doi.org/10.1016/j.apsb.2023.08.003
Vancouver
Niu X, Wu M, Li G, Zhou X, Cao W, Zhai W, et al. Identification and optimization of peptide inhibitors to block VISTA/PSGL-1 interaction for cancer immunotherapy. Acta Pharmaceutica Sinica B. 2023;13(11):4511-4522. doi:10.1016/j.apsb.2023.08.003
BibTeX
@article{Niu2023,
author = {Niu, Xiaoshuang and Wu, Menghan and Li, Guodong and Zhou, Xiuman and Cao, Wenpeng and Zhai, Wenjie and Wu, Aijun and Zhou, Xiaowen and Jin, Shengzhe and Chen, Guanyu and Li, Yanying and Du, Jiangfeng and Wu, Yahong and Qiu, Lu and Zhao, Wenshan and Gao, Yanfeng},
title = {Identification and optimization of peptide inhibitors to block VISTA/PSGL-1 interaction for cancer immunotherapy},
journal = {Acta Pharmaceutica Sinica B},
year = {2023},
volume = {13},
number = {11},
pages = {4511--4522},
doi = {10.1016/j.apsb.2023.08.003}
}
EUVIMED